Impact of diabetes mellitus on benefit of β-blocker therapy after myocardial infarction
Zaatari G, Bello D, Blandon C, et al.
Am J Cardiol. 2023;S0002-9149(23)00232-1.
Leggi
Zaatari G, Bello D, Blandon C, et al.
Am J Cardiol. 2023;S0002-9149(23)00232-1.
Leggi
Butler J, Packer M, Siddiqi TJ, et al.
J Am Coll Cardiol. 2023;81(19):1902–1914.
Leggi
Yang Z, Wu Y , Xu L, et al.
Diabetologia. Pub. online 13 May 2023.
Leggi
Pei Y, Shu Y, Deng B , Liu Y
BMC Endocr Disord. 2023;23(1):98.
Leggi
Zhang Y, Liu L, Wei C, et al.
BMC Med. 2023;21(1):174.
Leggi
Simmons D, Immanuel J, Hague WM, et al.
N Engl J Med. Pub. online 5 May 2023.
Leggi
Philis-Tsimikas A, Asong M, Franek E, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00093-1.
Leggi
Piona C, Marigliano M, Roncarà C, et al.
Diabetes Technol Ther. Pub. online 8 May 2023.
Leggi
Golla KK, Gupta Y, Goyal A, et al.
Diabetes Technol Ther. Pub. online 27 Apr 2023.
Leggi
Chetboun M, Drumez E, Ballou C, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00082-7.
Leggi